Does DABRAFENIB Cause Squamous cell carcinoma? 94 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 94 reports of Squamous cell carcinoma have been filed in association with DABRAFENIB (Tafinlar). This represents 0.5% of all adverse event reports for DABRAFENIB.
94
Reports of Squamous cell carcinoma with DABRAFENIB
0.5%
of all DABRAFENIB reports
5
Deaths
6
Hospitalizations
How Dangerous Is Squamous cell carcinoma From DABRAFENIB?
Of the 94 reports, 5 (5.3%) resulted in death, 6 (6.4%) required hospitalization, and 1 (1.1%) were considered life-threatening.
Is Squamous cell carcinoma Listed in the Official Label?
Yes, Squamous cell carcinoma is listed as a known adverse reaction in the official FDA drug label for DABRAFENIB.
What Other Side Effects Does DABRAFENIB Cause?
Pyrexia (3,788)
Death (2,740)
Malignant neoplasm progression (1,667)
Fatigue (1,328)
Nausea (1,300)
Chills (1,235)
Rash (1,078)
Vomiting (907)
Diarrhoea (901)
Headache (697)
What Other Drugs Cause Squamous cell carcinoma?
ADALIMUMAB (456)
RUXOLITINIB (413)
TACROLIMUS (327)
INFLIXIMAB (313)
RITUXIMAB (313)
LENALIDOMIDE (304)
PREDNISONE (267)
RANITIDINE (260)
CYCLOSPORINE (254)
METHOTREXATE (252)
Which DABRAFENIB Alternatives Have Lower Squamous cell carcinoma Risk?
DABRAFENIB vs DABRAFENIB\TRAMETINIB
DABRAFENIB vs DACARBAZINE
DABRAFENIB vs DACLATASVIR
DABRAFENIB vs DACLIZUMAB
DABRAFENIB vs DACOMITINIB